Biology subjects

Casasampere, M.

Publications and source records attributed to Casasampere, M..

3 recordsLinked to original sources

bioRxiv2026

Mammarenavirus-Induced Remodeling of the Cellular Lipid Landscape Reveals Sphingolipid Metabolism as a Novel Target for Antiviral Intervention

Several mammarenaviruses (MaAv) cause severe and often life-threatening disease in humans and represent major public health threats in their endemic regions. Lassa (LASV) and Junin (JUNV) MaAv, endemic to Western Africa and the Argentine Pampas, respectively, are etiologic agents of viral hemorrhagic fevers associated with high morbidity and mortality. In addition, the globally distributed MaAv lymphocytic choriomeningitis virus (LCMV) is an underrecognized human pathogen capable of causing severe congenital disease and fatal infections in immunocompromised individuals. Despite their public health importance, no FDA-approved vaccines or virus-specific antiviral therapies exist to prevent and treat human MaAv infections. Current treatment relies on the off-label use of ribavirin whose therapeutic efficacy remains controversial. These findings underscore the urgent need to develop effective antiviral strategies against human pathogenic MaAv. Here, we investigated the impact of LCMV infection on host lipid metabolism using an integrated transcriptomic and lipidomic approach. Our data reveal extensive time-dependent remodeling of the cellular lipid landscape, with particularly prominent alterations in sphingolipid and fatty acid metabolic pathways. Functional interrogation of these pathways using pharmacological inhibitors identified acetyl-CoA carboxylase (ACC) and neutral sphingomyelinase 2 (nSMase2) as host factors contributing to efficient viral replication. Notably, inhibition of nSMase2 reduced infectious virus production by 2 logs of infectious virus. Our findings showed that LCMV reprograms host lipid metabolism to facilitate infection and identified sphingolipid turnover as a promising target for host-directed antiviral strategies against MaAv infections.

microbiology↗

bioRxiv2026

Rho1 and Rgf3 regulate the expansion of the nuclear envelope during fission yeast mitosis/cytokinesis

The nuclear envelope (NE) surrounds the genetic material and is continuous with the endoplasmic reticulum (ER). In yeast and other organisms undergoing closed mitosis, nuclear envelope expansion (NME) is strictly required to accommodate spindle elongation and ensure proper chromosome segregation within a single nuclear compartment. Failure to expand the NE during mitosis leads to chromosome missegregation. Here, we show that deletion of the unstructured N-terminal domain of Rgf3, a Rho1-specific guanine nucleotide exchange factor (GEF), causes early mitotic defects that produce the characteristic "cut" phenotype of untimely cell division. The rgf3{Delta}N2 mutant displays spindle buckling, a hallmark of anaphase nuclei unable to properly expand the NE. From yeast to mammals, phosphatidic acid (PA)--a key precursor in phospholipid biosynthesis--is metabolized via two competing pathways, the cytidine diphosphate-diacylglycerol (CDP-DAG) and the Kennedy pathways, both contributing to lipid membrane homeostasis. We provide evidence that impaired Rho1 activation in rgf3{Delta}N2 selectively disrupts phospholipid synthesis through the CDP-choline branch of the Kennedy pathway. Thus, Rho1 promotes mitotic progression by modulating phospholipid biosynthesis to enable efficient NME during anaphase. HighlightsThe N-terminus of Rgf3 is required for proper nuclear envelope expansion (NME) during anaphase. The structurally flexible N-terminal domain of Rgf3 is essential for localized Rho1 activation. Active Rho1 drives mitotic membrane growth by modulating phospholipid synthesis through the Kennedy pathway.

Cell Biology↗

bioRxiv2022

Pharmacological elevation of cellular dihydrosphingomyelin provides a novel antiviral strategy against West Nile virus infection

Flavivirus life cycle is strictly dependent on cellular lipid metabolism. Polyphenols like gallic acid and its derivatives are promising lead compounds for new therapeutic agents as they can exert multiple pharmacological activities, including the alteration of lipid metabolism. The evaluation of our own collection of polyphenols against West Nile virus, a representative medically relevant flavivirus, led to the identification of N,N'-(dodecane-1,12-diyl)bis(3,4,5-trihydroxybenzamide) and its 2,3,4-trihydroxybenzamide regioisomer as selective antivirals with low cytotoxicity and high antiviral activity (EC50 of 2.2 and 0.24 M, respectively in Vero cells; EC50 of 2.2 and 1.9 M, respectively in SH-SY5Y cells). These polyphenols also inhibited the multiplication of other flaviviruses, namely Usutu, dengue, and Zika viruses, exhibiting lower antiviral or negligible antiviral activity against other RNA viruses. The mechanism underlying their antiviral activity against WNV involved the alteration of sphingolipid metabolism. These compounds inhibited ceramide desaturase (Des1) promoting the accumulation of dihydrosphingomyelin (dhSM), a minor component of cellular sphingolipids with important roles on membrane properties. Addition of exogenous dhSM, or Des1 blockage by using the reference inhibitor GT-11, confirmed the involvement of this pathway in WNV infection. These results unveil the potential of novel antiviral strategies based on the modulation of the cellular levels of dhSM and Des1 activity for the control of flavivirus infection.

microbiology↗